TER119 Mouse PBL Staining Problems

From: dflowers (dflowers@fhcrc.org)
Date: Mon Dec 04 2000 - 13:14:59 EST


We are using TER119-PE from Pharmingen to stain mouse erythroid cells.
This is one antibody of many that we are using to study lineage
repopulation capacity of transplanted cells. TER119 antibody recognizes
mouse erythrocytes and should also recognize any nucleated red cells
present in the blood. Normally we do an RBC lysis prior to staining
since this should not lyse the nucleated cells which are the cells we
are interested in. The problem is that we are seeing nonspecific
staining of other non erythroid cells with TER119 as evidenced by two
color staining with other markers for B,T, and myeloid cells. All other
antibodies we use stain clean and specific.  We always pretreat the
cells with Fc block from Pharmingen to reduce nonspecific binding, and
we always compare our staining to an isotype matched control.  A titer
of TER119 showed the same titer curves for binding to RBCs and non
erythroid cells which suggested that this nonspecific staining was not
some low affinity binding.   Staining was then compared on non-RBC lysed
cells, lysed cells, and mononuclear cells harvested from a 1.077
ficoll-hypaque density gradient. Nonspecific staining of non erythroid
cells was very low on cells from the Ficoll gradient, was terrible on
non lysed cells, and was intermediate on RBC lysed cells. All this led
me to think that TER119 may be staining RBCs bound to nucleated cells.
We do our staining with PBS/2%Fetal bovine serum. PI is used to mark
dead cells which are very few in these samples.  Does this sound like
the likely reason? Is there something I could change to eliminate this
problem? All suggestions appreciated. I am wondering if there is
something I can do to avoid the Ficoll since cell numbers for staining
are limited and we also want to assess the presence of mature
granulocytes. The Ficoll would have to be used only for cells stained
for TER and that would be painful!

Thanks!
Dave Flowers
Program in Pediatric Oncology
Fred Hutchinson Cancer Research Center
Seattle, WA, USA



This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:40 EST